2022 Medlab Asia and Asia Health-Thailand

2022 Medlab Asia and Asia Health-Thailand

Asia Health 2022 will be welcoming world-class suppliers and industry leaders In-person as well as top-of-the-line buyers in the healthcare sector to explore the APAC market.

Hangzhou AllTest Biotech Co.,Ltd is a biotechnology company that partakes in research, manufacture, sales, and marketing of in vitro diagnostic products. ALLTEST focuses on the subdivision of POCT in the IVD industry. The main products cover immunologic diagnosis, biochemical analysis, fluorescence detection, molecular diagnosis, etc. At present, there are more than 700 kinds of products on the market, which are sold in more than 100 countries and regions around the world.

We focuses great importance on technological improvement and innovation, and is at the leading domestic level in the fields of biological raw material research and development, immunochromatography technology, in vitro diagnostic equipment, biochemical technology and fluorescence technology. With strong technology extension and iterative innovation, our R&D team has a strong ability to launch new products every month, and constantly meet the renewed needs of our customers.

New products and updated business lines will bring a higher level of service experience to our customers. In preparation for the show, we have been working behind the scenes to create a new product brochure and posters that will be on display at our booth. You and your company's representatives will be able to experience ALLTEST’ s high quality rapid test products and new medical instruments at our booth.

Our products have been registered and certified by China NMPA,EU IVDR, EU CE, US FDA, Canada Health Canada, Australia TGA, Brazil Anvisa, etc.

This medical exhibition is a truly international attendance!

We are honored to be invited as one of the exhibitors and we sincerely invite your company and your representatives to come and discuss business related POCT products .